The approval allows Eyenuk’s AI eye screening system, already approved for detection of diabetic retinopathy, to aid millions of additional patients at risk for vision loss LOS ANGELES, January 31, …
Academic leaders will review their experience with the technology during a symposium at AAO 2022, the American Academy of Ophthalmology annual meeting CHICAGO, September 30, 2022 — From the American …
Program selects Eyenuk’s EyeArt AI system to make vision-saving screening more accessible in remote Ontario communities LOS ANGELES and TORONTO, August 16, 2022 – Vision Loss Rehabilitation Canada (VLRC), Canada’s …
LOS ANGELES, June 1, 2022 – Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI …
July 28, 2021 – HealthCare Dynamics International (HCDI), a minority, woman-owned, small business specializing in health care quality improvement and transformation, recently implemented the EyeArt® artificial intelligence (AI) system for …
HCD International Adopts Eyenuk AI Technology to Close HEDIS Gaps for Health Plans Read More »
Eyenuk’s clinical partner in Virginia has been awarded a government telemedicine grant to improve diabetic eye screening in rural Virginia. Clinical partners must be located in rural Virginia to be …
EyeArt is the First FDA Cleared AI Technology for Autonomous Detection of Both More than mild and Vision-Threatening Diabetic Retinopathy Los Angeles, CA, August 5, 2020 — Eyenuk, Inc., a …
In cooperation with the World Diabetes Foundation and the Ministry of Health of Armenia, the Armenian EyeCare Project is implementing a nationwide screening program using state-of-the-art AI technology. 350 patients …
New research shows that an automated, artificial intelligence (AI) screening system accurately detects diabetic retinopathy 95.5 percent of the time. The system doesn’t require the input of an expert ophthalmologist …
Landmark Study of Over 100,000 Diabetes Patient Visits Published in the Journal Diabetes Technology and Therapeutics Validates the Prowess of the EyeArt AI System for Diabetic Retinopathy Screening LOS ANGELES, …
July 30, 2019. Chicago, IL: The results of a prospective study, titled “Artificial Intelligence Screening for Diabetic Retinopathy: Analysis from a Pivotal Multi-center Prospective Clinical Trial,” were presented at the …
Strong EyeArt® Accuracy Results Presented by Professor Jennifer Lim at ASRS 2019 Read More »
LOS ANGELES, June 5, 2019 – Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today …
LOS ANGELES, CA, May 16, 2019 – Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced …
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced today that it will release results …
LOS ANGELES, Calif., April 28, 2019 – Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™, announced …
Combining the high accuracy of AI disease detection with the accepted practice of human grading, the EyeScreen™ Service for diabetic retinopathy (DR) identifies cases of referable DR in any clinical …
EyeScreen™ Human+AI Diagnostic Service to be launched at ATA 2019 Read More »
A new study published in the international ‘Eye’ journal (Springer Nature) demonstrated very high sensitivity for detecting any diabetic retinopathy (95.8%) and sight-threatening diabetic retinopathy (99.1%) using EyeArt™ automated screening software with Remidio Fundus …
World Diabetes Day is the world’s largest diabetes awareness campaign. This year’s theme, Women and Diabetes, promotes the importance of access for all women with diabetes to education, treatment and …
Preventing the preventable: Combating diabetic retinopathy in at-risk women Read More »
Most people know that diabetes is about insulin abnormalities, whether it’s not producing enough insulin or body’s inability to recognize insulin and use it properly (in type 1 diabetes) or …
It starts out small enough. Your vision seems slightly blurred. At first you just think it’s a sign of increasing age; you notice that reading text is a little harder. …
